United Therapeutics Corporation shares owned by Russell Investments
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Russell Investments
from 13F filings
Historical chart of Russell Investments investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by Russell Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by Russell Investments
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $18M | 43k | 419.21 |
| 2025-06-30 | $14M | 48k | 287.35 |
| 2025-03-31 | $20M | 64k | 308.27 |
| 2024-12-31 | $31M | 88k | 352.84 |
| 2024-09-30 | $23M | 65k | 358.35 |
| 2024-06-30 | $20M | 63k | 318.55 |
| 2024-03-31 | $15M | 63k | 229.72 |
| 2023-12-31 | $18M | 80k | 219.89 |
| 2023-09-30 | $26M | 114k | 225.87 |
| 2023-06-30 | $26M | 116k | 220.75 |
| 2023-03-31 | $30M | 133k | 223.95 |
| 2022-12-31 | $34M | 121k | 278.09 |
| 2022-09-30 | $33M | 159k | 209.29 |
| 2022-06-30 | $24M | 102k | 238.08 |
| 2022-03-31 | $15M | 84k | 179.40 |
| 2021-12-31 | $33M | 153k | 215.96 |
| 2021-09-30 | $42M | 226k | 184.57 |
| 2021-06-30 | $47M | 264k | 179.38 |
| 2021-03-31 | $55M | 326k | 167.26 |
| 2020-12-31 | $58M | 382k | 151.72 |
| 2020-09-30 | $45M | 443k | 100.99 |
| 2020-06-30 | $47M | 395k | 119.96 |
| 2020-03-31 | $26M | 281k | 94.01 |
| 2019-12-31 | $16M | 179k | 87.94 |
| 2019-09-30 | $13M | 157k | 79.74 |
| 2019-06-30 | $14M | 180k | 77.85 |
| 2019-03-31 | $22M | 184k | 117.37 |
| 2018-12-31 | $21M | 197k | 108.19 |
| 2018-09-30 | $27M | 209k | 127.64 |
| 2018-06-30 | $20M | 181k | 112.75 |
| 2018-03-31 | $29M | 260k | 110.21 |
| 2017-12-31 | $40M | 266k | 149.21 |
| 2017-09-30 | $41M | 352k | 117.20 |
| 2017-06-30 | $41M | 315k | 129.74 |
| 2017-03-31 | $48M | 356k | 135.40 |
| 2016-12-31 | $62M | 427k | 143.92 |
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation